SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease

55Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

Serine-arginine protein kinases 2 (SRPK2) is a cell cycle-regulated kinase that phosphorylates serine/arginine domain-containing proteins and mediates pre-mRNA splicing with unclear function in neurons. Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau-dependent microtubule polymerization, and inhibits axonal elongationin neurons. DepletionofSRPK2in dentate gyrus inhibits tau phosphorylation in APP/PS1 mouse and alleviates the impaired cognitive behaviors. The defective LTP in APP/PS1 mice is also improved after SRPK2 depletion. Moreover, active SRPK2isincreasedinthe cortexof APP/PS1 mice and the pathological structures of human Alzheimer's disease (AD) brain. Therefore, our study suggestsSRPK2may contributetothe formationofhyperphosphorylated tau and the pathogenesis of AD. © 2012 the authors.

Cite

CITATION STYLE

APA

Hong, Y., Chan, C. B., Kwon, I. S., Li, X., Song, M., Lee, H. P., … Ye, K. (2012). SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer’s disease. Journal of Neuroscience, 32(48), 17262–17272. https://doi.org/10.1523/JNEUROSCI.3300-12.2012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free